The most important financial indicators for the company S T K Pharma Srl - Unique Identification Number 33512805:
sales in 2023 was
11.072
euro, registering a net profit of
469
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Depozitari having the NACE code 5210.
Sales, Profit, Employees, Debts, Capitals, Financial Results -
S T K Pharma Srl
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Sales - EUR
0
19.787
71.198
82.579
68.091
53.458
69.875
2.638
19
11.072
Total Income - EUR
0
19.717
71.237
88.481
68.219
53.626
71.281
2.777
19
22.192
Total Expenses - EUR
823
25.482
62.066
87.835
70.677
55.034
63.759
5.352
10.070
21.502
Gross Profit/Loss - EUR
-823
-5.765
9.171
646
-2.458
-1.407
7.522
-2.575
-10.052
691
Net Profit/Loss - EUR
-823
-6.363
8.087
-243
-3.144
-1.944
6.809
-2.658
-10.052
469
Employees
0
1
2
4
4
4
4
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 59,428.3%, from 19 euro in the year 2022, to 11.072 euro in 2023.
The Net Profit increased by 469 euro, from 0 euro in 2022, to 469 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
S T K Pharma Srl - CUI 33512805
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
83
699
460
229
45
486
389
337
288
982
Current Assets
2.485
11.533
17.229
6.719
9.148
12.997
13.918
10.838
8.789
10.998
Inventories
1.788
7.495
16.381
4.318
8.303
11.975
12.298
10.151
8.388
3.851
Receivables
591
3.058
332
1.703
410
561
1.088
5
393
5.384
Cash
105
980
515
698
435
461
533
682
8
1.762
Shareholders Funds
-779
-7.148
745
-190
-3.331
-5.210
1.698
-998
-11.045
-10.543
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
3.347
19.380
16.944
7.139
12.525
18.693
12.619
12.174
20.121
22.523
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"5210 - 5210"
CAEN Financial Year
4776
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
10.998 euro in 2023 which includes Inventories of
3.851 euro, Receivables of
5.384 euro and cash availability of
1.762 euro.
The company's Equity was valued at
-10.543 euro, while total Liabilities amounted to
22.523 euro.
Equity increased by 469 euro, from -11.045 euro in 2022, to -10.543 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - S T K Pharma Srl